News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

David Dorr, MD, MS

Articles by David Dorr, MD, MS

Reporting Only ‘Unanticipated’ AEs of Trial Drugs Would Reduce IRB Workload, But Would Patient Safety Suffer?

ByDavid Dorr, MD, MS,Charles L. Bennett, MD, PhD

November 1st 2006

Enrollment in clinical trials is crucialto continued scientific discovery andimproved patient care.

Latest Updated Articles

Reporting Only ‘Unanticipated’ AEs of Trial Drugs Would Reduce IRB Workload, But Would Patient Safety Suffer?
November 1st 2006

Trending on CancerNetwork

FDA Approves Nivolumab/AVD in Untreated Hodgkin Lymphoma

FDA Grants Fast Track Designation to FG001 for High-Grade Glioma Surgery

Liquid Biopsies, Blood-Based MCED Tests for Detecting CRC in Young Patients

Potential Rusfertide Approval May Offer More Control of Polycythemia Vera

Comparison of the 3 Most Commonly Used Modified PD-1 Inhibitors Plus Chemotherapy in Inoperable Wild-Type Non–Small Cell Lung Cancer